Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.22 +0.47 (+3.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ultragenyx Pharmaceutical (RARE) Cash from Financing Activities (2013 - 2025)

Updated

Ultragenyx Pharmaceutical (RARE) posted Cash from Financing Activities of $394.19 million for Q4 2025, compared with $2.95 million a year earlier.

Analysis

Ultragenyx Pharmaceutical (RARE) Cash from Financing Activities (2013 - 2025) Analysis & Trends

For FY2025, Ultragenyx Pharmaceutical's Cash from Financing Activities came in at $478 million, up 19.8% from FY2024.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
  • In prior years, Ultragenyx Pharmaceutical's Cash from Financing Activities was $399 million in FY2024 (+2.8%), $388 million in FY2023 (-22.6%), $501.21 million in FY2022 (+322.8%) and $118.55 million in FY2021 (-80.3%).
  • The Q4 2025 figure stands as the highest quarterly Cash from Financing Activities since Q3 2022.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q2 2023, with growth of 465.7%; the weakest was Q4 2024, with a decline of 99.1%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was -$192,000 (Q3 2025), $83.84 million (Q2 2025) and $157,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -8.78 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -5.05 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -47.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 2.34 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -3.66 Bn
10 Ultragenyx Pharmaceutical 1.50 Bn -302.56 Mn 180.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 394.19 Mn
Sep 30, 2025 -192,000.00
Jun 30, 2025 83.84 Mn
Mar 31, 2025 157,000.00
Dec 31, 2024 2.95 Mn
Sep 30, 2024 11.17 Mn
Jun 30, 2024 384.94 Mn
Mar 31, 2024 -58,000.00
Dec 31, 2023 330.47 Mn
Sep 30, 2023 25.23 Mn
Jun 30, 2023 33.02 Mn
Mar 31, 2023 -722,000.00
Dec 31, 2022 1.88 Mn
Sep 30, 2022 491.88 Mn
Jun 30, 2022 5.84 Mn
Mar 31, 2022 1.61 Mn
Dec 31, 2021 85.73 Mn
Sep 30, 2021 7.55 Mn
Jun 30, 2021 12.63 Mn
Mar 31, 2021 12.65 Mn
API Access

Ultragenyx Pharmaceutical Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RARE&period=max&api_key=YOUR_API_KEY